COVID-19: FDA Tells Test Makers How To Minimize Effects Of Variants
Executive Summary
The US Food and Drug Administration has taken additional steps to ensure mutations of the COVID-19 virus do not negatively impact the efficacy of tests.
You may also be interested in...
Overflow Issue With Abbott COVID Tests Could Result In False Positives
The mixture in some faulty Abbott PCR tests could cause COVID-19 positive samples to flow into neighboring negative samples, resulting in false-positive results.
FDA Launches New Webpage Dedicated To AR And VR Medical Devices
The US Food and Drug Administration has launched a new webpage dedicated to medical devices that incorporate augmented reality and virtual reality technologies. The agency has approved some 39 AR/VR devices.
FDA Updates Abiomed’s Heart Pump Labeling After Post-Approval Clinical Study
The US Food and Drug Administration recently updated the labeling of Abiomed’s Impella RP System to reflect the latest results from a clinical study on the device. The FDA first approved the heart pump system in September 2017.